Neogen Total Stockholder Equity vs Cash Analysis
| NEOG Stock | USD 12.14 0.18 1.51% |
Neogen financial indicator trend analysis is infinitely more than just investigating Neogen recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Neogen is a good investment. Please check the relationship between Neogen Total Stockholder Equity and its Cash accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neogen. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. For more detail on how to invest in Neogen Stock please use our How to Invest in Neogen guide.
Total Stockholder Equity vs Cash
Total Stockholder Equity vs Cash Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Neogen Total Stockholder Equity account and Cash. At this time, the significance of the direction appears to have almost no relationship.
The correlation between Neogen's Total Stockholder Equity and Cash is 0.19. Overlapping area represents the amount of variation of Total Stockholder Equity that can explain the historical movement of Cash in the same time period over historical financial statements of Neogen, assuming nothing else is changed. The correlation between historical values of Neogen's Total Stockholder Equity and Cash is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Stockholder Equity of Neogen are associated (or correlated) with its Cash. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash has no effect on the direction of Total Stockholder Equity i.e., Neogen's Total Stockholder Equity and Cash go up and down completely randomly.
Correlation Coefficient | 0.19 |
| Relationship Direction | Positive |
| Relationship Strength | Insignificant |
Total Stockholder Equity
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.Cash
Cash refers to the most liquid asset of Neogen, which is listed under current asset account on Neogen balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Neogen customers. The amounts must be unrestricted with restricted cash listed in a different Neogen account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.Most indicators from Neogen's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Neogen current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neogen. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. For more detail on how to invest in Neogen Stock please use our How to Invest in Neogen guide.At this time, Neogen's Enterprise Value Multiple is most likely to increase significantly in the upcoming years. The Neogen's current Enterprise Value is estimated to increase to about 3.8 B, while Tax Provision is projected to decrease to roughly 707.9 K.
| 2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 243.0M | 406.0M | 466.8M | 490.2M | Total Revenue | 527.2M | 822.4M | 945.8M | 993.1M |
Neogen fundamental ratios Correlations
Click cells to compare fundamentals
Neogen Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Neogen fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 797.2M | 920.2M | 992.9M | 4.6B | 5.2B | 5.5B | |
| Other Current Liab | 22.8M | 25.0M | 36.3M | 60.9M | 70.0M | 73.5M | |
| Total Current Liabilities | 48.5M | 53.6M | 77.8M | 145.5M | 167.3M | 175.7M | |
| Total Stockholder Equity | 725.2M | 840.4M | 887.4M | 3.1B | 3.6B | 3.8B | |
| Property Plant And Equipment Net | 78.7M | 100.5M | 110.6M | 198.7M | 228.6M | 240.0M | |
| Net Debt | (342.6M) | (379.8M) | 605.6M | 736.8M | 663.1M | 696.2M | |
| Retained Earnings | 478.7M | 539.6M | 587.9M | 565.0M | 649.8M | 682.3M | |
| Cash | 343.7M | 381.1M | 381.1M | 163.2M | 187.7M | 197.1M | |
| Non Current Assets Total | 259.8M | 328.7M | 366.1M | 4.0B | 4.6B | 4.8B | |
| Non Currrent Assets Other | 2.2M | 2.0M | 2.2M | 15.2M | 17.5M | 15.5M | |
| Cash And Short Term Investments | 343.7M | 381.1M | 381.1M | 245.6M | 282.4M | 296.5M | |
| Net Receivables | 84.7M | 91.8M | 99.7M | 153.3M | 176.2M | 185.1M | |
| Common Stock Shares Outstanding | 105.7M | 107.1M | 108.0M | 188.9M | 217.2M | 228.1M | |
| Liabilities And Stockholders Equity | 797.2M | 920.2M | 992.9M | 4.6B | 5.2B | 5.5B | |
| Non Current Liabilities Total | 23.5M | 26.2M | 27.7M | 1.3B | 1.5B | 1.5B | |
| Inventory | 95.1M | 100.7M | 122.3M | 133.8M | 153.9M | 161.6M | |
| Other Current Assets | 14.0M | 17.8M | 23.8M | 53.3M | 61.3M | 64.4M | |
| Other Stockholder Equity | 257.7M | 295.0M | 310.0M | 2.6B | 3.0B | 3.1B | |
| Total Liab | 72.0M | 79.8M | 105.6M | 1.4B | 1.6B | 1.7B | |
| Property Plant And Equipment Gross | 80.6M | 102.9M | 215.5M | 318.9M | 366.7M | 385.0M | |
| Total Current Assets | 537.4M | 591.5M | 626.8M | 585.9M | 673.8M | 707.5M | |
| Accumulated Other Comprehensive Income | (19.7M) | (11.4M) | (27.8M) | (33.3M) | (29.9M) | (28.4M) | |
| Intangible Assets | 66.6M | 92.3M | 107.5M | 1.6B | 1.8B | 1.9B | |
| Accounts Payable | 25.7M | 23.9M | 34.6M | 76.7M | 88.2M | 92.6M | |
| Common Stock Total Equity | 8.5M | 17.2M | 17.2M | 34.6M | 39.8M | 41.8M | |
| Short Term Investments | 277.4M | 305.5M | 336.6M | 82.3M | 94.7M | 91.9M | |
| Common Stock | 8.5M | 17.2M | 17.2M | 34.6M | 39.8M | 37.8M | |
| Other Liab | 22.6M | 26.2M | 27.7M | 375.7M | 432.1M | 453.7M | |
| Other Assets | 2.2M | 2.0M | 4.8B | 15.2M | 17.5M | 16.6M | |
| Good Will | 181.1M | 228.3M | 255.5M | 3.8B | 4.3B | 4.6B | |
| Property Plant Equipment | 78.7M | 100.5M | 110.6M | 198.7M | 228.6M | 240.0M | |
| Net Tangible Assets | 599.6M | 612.1M | 887.4M | 3.1B | 3.6B | 3.8B | |
| Retained Earnings Total Equity | 478.7M | 539.6M | 587.9M | 565.0M | 649.8M | 382.8M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neogen. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. For more detail on how to invest in Neogen Stock please use our How to Invest in Neogen guide.You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Neogen Stock analysis
When running Neogen's price analysis, check to measure Neogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neogen is operating at the current time. Most of Neogen's value examination focuses on studying past and present price action to predict the probability of Neogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neogen's price. Additionally, you may evaluate how the addition of Neogen to your portfolios can decrease your overall portfolio volatility.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |
Is Neogen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neogen. If investors know Neogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.86) | Earnings Share 0.02 | Revenue Per Share 4.293 | Quarterly Revenue Growth 0.048 | Return On Assets 0.0179 |
The market value of Neogen is measured differently than its book value, which is the value of Neogen that is recorded on the company's balance sheet. Investors also form their own opinion of Neogen's value that differs from its market value or its book value, called intrinsic value, which is Neogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neogen's market value can be influenced by many factors that don't directly affect Neogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Neogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.